OTSUKA AMERICA PHARMACEUTICALS, INC

ABILIFY ASIMTUFII

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

OTSUKA AMERICA PHARMACEUTICALS, INC

Abilify Asimtufii HCPCS:

C9152

HCPCS Code Descriptor:

Injection, aripiprazole, (abilify asimtufii), 1 mg

Category:

C Code

Abilify Asimtufii NDCs:

No actively aligned NDCs found

Primary Type:

Psychiatric

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Intramuscular

Abilify Asimtufii CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Abilify Asimtufii:

ABILIFY ASIMTUFII is a Psychiatric drug manufactured by Otsuka America and administered via the intramuscular route of administration. The C Code: C9152 is aligned to the drug ABILIFY ASIMTUFII.

Abilify Asimtufii is a type of atypical antipsychotic used to treat schizophrenia and bipolar I disorder in adults. It is given by extended-release injection once every two months. Abilify Asimtufii is thought to work balancing the levels of serotonin and dopamine in the brain.

ACCESS PRICING AND MORE BY REGISTERING

C9152 Added Date:

October 1, 2023

C9152 Effective Date:

October 1, 2023

C9152 Termination Date:

December 31, 2023

We have not yet identified a manufacturer source of Abilify Asimtufii billing and coding information.
Abilify Asimtufii patient assistance information can be found through Otsuka Patient Assistance at the URL: https://www.otsukapatientassistance.com/
ABILIFY ASIMTUFII prescribing information can be found at the link below:
Information regarding ABILIFY ASIMTUFII’s side effects can be found at MedlinePlus